Skip to content
OpenCapital
Get started

Crinetics Pharmaceuticals CRNX Q1 2026 earnings

Reported May 7, 2026 · After market close

Revenue$10.7MBeat by $2.2M
EPS-$1.23Miss by $0.01
Revenue estimate$8.5M
EPS estimate-$1.22

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$14.8M
EPS estimate-$1.23

Financials

Q1 2026

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation & ratios

Valuation

as of 07/28/26
See full
Market cap$8.87B+213%
Enterprise value$8.81B+211%
P/S491.2×-1,548×

Profitability

See full
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0×0.0×
Current ratio18.6×-3.9×

Segments

By segment

See full
Reportable Segment$10.7M+2,873%

By product

See full
Collaboration and license revenue$428.0K+18.6%

Versus estimates

Revenue

Q1 2026$10.7MBeat by $2.2M
Q4 2025$6.2MBeat by $1.7MQ3 2025$143.0KMiss by $4.2MQ2 2025$1.0MBeat by $637.0KQ1 2025$361.0KBeat by $13.1K

Diluted EPS

Q1 2026-$1.23Miss by $0.01
Q4 2025-$1.29Beat by $0.08Q3 2025-$1.38Miss by $0.11Q2 2025-$1.23Miss by $0.10Q1 2025-$1.04Miss by $0.05Q4 2024-$0.88Beat by $0.04

Ask the moment Crinetics Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Crinetics Pharmaceuticals report Q1 2026 earnings?
Crinetics Pharmaceuticals (CRNX) reported Q1 2026 earnings on May 7, 2026 after market close.
What were Crinetics Pharmaceuticals's Q1 2026 revenue and EPS?
Crinetics Pharmaceuticals reported revenue of $10.7M and eps of $-1.23 for Q1 2026.
Did Crinetics Pharmaceuticals beat estimates in Q1 2026?
Revenue beat the consensus estimate of $8.5M by $2.2M. EPS missed the consensus estimate of $-1.22 by $0.01.
How did Crinetics Pharmaceuticals's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2873.4% from $361.0K a year earlier and eps declined 18.3% from $-1.04.
Where can I find Crinetics Pharmaceuticals's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001658247-26-000039) and the 10-Q periodic report (0001658247-26-000040) directly on SEC EDGAR. The filing index links above go to sec.gov.